Liver Disease Clinical Trials in Utah

27 recruiting studies across 7 cities

All Trials in Utah

Phase
Trial Phase Location
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 2Farmington
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This ConditionPhase 2Murray
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Phase 3Murray
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Phase 3Ogden
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Phase 3Ogden
A Prospective Database of Infants With Cholestasis—Salt Lake City
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment—Salt Lake City
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition—Salt Lake City
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Phase 2Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Phase 1/2Salt Lake City
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)—Salt Lake City
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant DiseasePhase 2Salt Lake City
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs—Salt Lake City
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)—Salt Lake City
Longitudinal Study of the Porphyrias—Salt Lake City
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/ASalt Lake City
Primary Sclerosing Cholangitis in Children—Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Salt Lake City
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2Salt Lake City
The Myelin Disorders Biorepository Project—Salt Lake City
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHPhase 3Sandy City
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASHPhase 3West Jordan
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHPhase 3West Jordan
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPhase 1West Valley City
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 1West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsPhase 1West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsPhase 1West Valley City

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.